Neil Gunn

Neil Gunn has extensive experience in the biotechnology and life sciences sectors, currently serving as a Non-Executive Board Member at Rarecells Inc and Genetic Signatures. Previously, Neil held the position of Chief Executive Officer at IDbyDNA and led the Roche Sequencing Unit as President and Head from 2016 to 2021. Neil's earlier roles include Head of Global Business at Roche Molecular Systems and Vice President of Commercialization at CaridianBCT. Neil's career began at Pall Corporation as Marketing Director for Europe and further included significant positions at Chiron Corporation. Neil earned a Ph.D. in Marine Microbiology from the University of Portsmouth, following studies at Nottingham Trent University.